| Financial Year |
March 31 2023 |
| Monetary Funds |
20,913,295.86 |
| Held-for-trading Financial Assets |
274,785,554.97 |
| Notes Receivable |
26,167,202.44 |
| Accounts Receivable |
27,366,109.73 |
| Advances to Suppliers |
9,943,919.67 |
| Other Receivables |
1,534,092.38 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
279,010,362.75 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
50,844,554.56 |
| Other Current Assets |
39,875,669.12 |
| Total Current Assets |
744,201,941.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,946,562.95 |
| Long-term Equity Investment |
9,613,529.89 |
| Investment Properties |
1,619,926.25 |
| Fixed Assetes |
459,077,617.90 |
| Under-construction Projects |
16,970,200.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
48,599,981.40 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
866,970.89 |
| Deferred Income Tax Assets |
10,477,650.11 |
| Other Non-Current Assets |
42,773,039.71 |
| Sub-Total of Non-Current Assets |
726,885,916.29 |
| Total Assets |
1,471,087,858.15 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
56,707,476.60 |
| Accounts Payable |
41,272,709.63 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
25,985.72 |
| Taxes Payable |
1,464,483.24 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
100,518.43 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
172,970.46 |
| Other Current Liabilities |
17,220,720.12 |
| Sub-Total of Current Liabilities |
173,465,435.40 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
28,986,563.73 |
| Total Liabilities |
202,451,999.13 |
| Paid-In Capital(Or Share Stock) |
418,923,580.00 |
| Capital Surplus |
495,466,196.12 |
| Surplus Reserve |
46,129,886.91 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
310,481,958.49 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,268,635,859.02 |
| Owner's Equity（Stockholder's Equity） |
1,268,635,859.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,471,087,858.15 |
